Home
About
Overview
Sharing Data
ORCID
Help
History (1)
A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium.
A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium. Gynecol Oncol. 2022 07; 166(1):44-49.
View in:
PubMed
subject areas
Antineoplastic Combined Chemotherapy Protocols
Bevacizumab
Cervix Uteri
Endometrial Neoplasms
Endometrium
Female
Humans
Indoles
Neoplasm Recurrence, Local
Uterine Cervical Neoplasms
authors with profiles
Debra L Richardson
Joan L Walker
Kai Ding
Laura L Holman
Robert S Mannel
Lauren E Dockery